Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Calvo

Showing results (81-90 of 127) with videos related to

Pageof 13
Sort By:
Therapeutic Advances in Gastroenterology|February 4, 2022
Preferences and satisfaction of IBD patients after switching from adalimumab 40 mg weekly to 80 mg every other week given as a single injection: the ADASCAL studyCarlos Taxonera, María Pilar Martínez-Montiel, Manuel Barreiro-de-Acosta, et al.
Inflammatory Bowel Diseases|April 5, 2013
Impact of current smoking on the clinical course of microscopic colitisFernando Fernández-Bañares, Monia R de Sousa, Antonio Salas, et al.
Vaccines|February 26, 2026
Feasibility and Safety of Autologous Dendritic Cell Vaccination Combined with Radio-Chemotherapy in Newly Diagnosed Glioblastoma: A Retrospective Single-Center SeriesInés Esparragosa Vázquez, Ascensión López-Díaz de Cerio, Susana Inoges, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|October 26, 2023
Myeloid-derived suppressor cells as a potential biomarker for recurrent pregnancy loss and recurrent implantation failure: Increased levels of MDSCs in recurrent reproductive failureNabil Subhi-Issa Marin, Eduardo de la Fuente-Muñoz, Raquel Gil-Laborda, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|March 9, 2019
The Harvey-Bradshaw Index Adapted to a Mobile Application Compared with In-Clinic Assessment: The MediCrohn StudyAna Echarri, Isabel Vera, Virginia Ollero, et al.
Journal of Clinical Medicine|February 12, 2021
Nocturnal Hypoxemia and CT Determined Pulmonary Artery Enlargement in SmokersMarta Marin-Oto, Luis M Seijo, Miguel Divo, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|December 28, 2022
Should Inflammatory Bowel Disease Clinicians Provide Their Patients with e-Health Resources? Patients' and Professionals' PerspectivesAna Echarri, José L Pérez-Calle, Marta Calvo, et al.
Crohn'S & Colitis 360|February 14, 2023
Treatment With Adalimumab 80 mg Every Other Week in Inflammatory Bowel Disease: Results of Treatment Intensification in Clinical PracticeMarta Calvo Moya, Yago González Lama, Belén Ruíz Antorán, et al.
Revista Espanola De Enfermedades Digestivas|November 20, 2020
Comparison of original and biosimilar infliximab (CTP-13) in biologic-naïve patients with Crohn's disease and ulcerative colitis: a retrospective, multicenter real-life study in SpainHelena Martínez-Lozano, José Miranda-Bautista, Yago González-Lama, et al.
Hepatology (Baltimore, Md.)|December 18, 2008
Randomized trial comparing pegylated interferon alpha-2b versus pegylated interferon alpha-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patientsMontserrat Laguno, Carmen Cifuentes, Javier Murillas, et al.
Pageof 13

Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
Therapeutic Advances in Gastroenterology|February 4, 2022
Preferences and satisfaction of IBD patients after switching from adalimumab 40 mg weekly to 80 mg every other week given as a single injection: the ADASCAL studyCarlos Taxonera, María Pilar Martínez-Montiel, Manuel Barreiro-de-Acosta, et al.
Inflammatory Bowel Diseases|April 5, 2013
Impact of current smoking on the clinical course of microscopic colitisFernando Fernández-Bañares, Monia R de Sousa, Antonio Salas, et al.
Vaccines|February 26, 2026
Feasibility and Safety of Autologous Dendritic Cell Vaccination Combined with Radio-Chemotherapy in Newly Diagnosed Glioblastoma: A Retrospective Single-Center SeriesInés Esparragosa Vázquez, Ascensión López-Díaz de Cerio, Susana Inoges, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|October 26, 2023
Myeloid-derived suppressor cells as a potential biomarker for recurrent pregnancy loss and recurrent implantation failure: Increased levels of MDSCs in recurrent reproductive failureNabil Subhi-Issa Marin, Eduardo de la Fuente-Muñoz, Raquel Gil-Laborda, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|March 9, 2019
The Harvey-Bradshaw Index Adapted to a Mobile Application Compared with In-Clinic Assessment: The MediCrohn StudyAna Echarri, Isabel Vera, Virginia Ollero, et al.
Journal of Clinical Medicine|February 12, 2021
Nocturnal Hypoxemia and CT Determined Pulmonary Artery Enlargement in SmokersMarta Marin-Oto, Luis M Seijo, Miguel Divo, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|December 28, 2022
Should Inflammatory Bowel Disease Clinicians Provide Their Patients with e-Health Resources? Patients' and Professionals' PerspectivesAna Echarri, José L Pérez-Calle, Marta Calvo, et al.
Crohn'S & Colitis 360|February 14, 2023
Treatment With Adalimumab 80 mg Every Other Week in Inflammatory Bowel Disease: Results of Treatment Intensification in Clinical PracticeMarta Calvo Moya, Yago González Lama, Belén Ruíz Antorán, et al.
Revista Espanola De Enfermedades Digestivas|November 20, 2020
Comparison of original and biosimilar infliximab (CTP-13) in biologic-naïve patients with Crohn's disease and ulcerative colitis: a retrospective, multicenter real-life study in SpainHelena Martínez-Lozano, José Miranda-Bautista, Yago González-Lama, et al.
Hepatology (Baltimore, Md.)|December 18, 2008
Randomized trial comparing pegylated interferon alpha-2b versus pegylated interferon alpha-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patientsMontserrat Laguno, Carmen Cifuentes, Javier Murillas, et al.
Pageof 13